FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

Data Compilation
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

Dexamethasone

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

93 API Suppliers, 27 USDMF, 13 CEP/COS, 6 JDMF, 4 EU WC, 7 KDMF, 26 NDC API, 1 VMF, 51 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

411 Drugs in Development

411 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

526 FDF Dossiers, 131 FDA Orange Book, 271 Europe, 26 Canada, 10 Australia, 18 South Africa, 70 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OPHTHALMIC - 0.1%, SUSPENSION/DROPS;OTIC - 0.3%;0.1%, OINTMENT;OPHTHALMIC - 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM, SUSPENSION/DROPS;OPHTHALMIC - 0.1%;0.3%, OINTMENT;OPHTHALMIC - 0.1%;0.3%, SUSPENSION/DROPS;OPHTHALMIC - 0.05%;0.3%, TABLET;ORAL - 0.5MG, TABLET;ORAL - 0.75MG, TABLET;ORAL - 1.5MG, TABLET;ORAL - 1MG, TABLET;ORAL - 2MG, TABLET;ORAL - 4MG, TABLET;ORAL - 6MG, SOLUTION;ORAL - 0.5MG/5ML, CONCENTRATE;ORAL - 1MG/ML, ELIXIR;ORAL - 0.5MG/5ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 3 Rochem International Inc, 7 SPI Pharma, 1 Pharm-RX Chemical, 6 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 9 Kirsch Pharma, 1 ACG Worldwide, 15 Actylis, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 3 CD Formulation, 10 Corel Pharma Chem, 1 Curia, 6 DFE Pharma, 3 Finar, 8 Gangwal Chemicals, 2 Gloria Interchem, 4 Ideal Cures, 3 Ingredion Pharma Solutions, 23 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 Nanjing Bold Chemical, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 30 Roquette, 15 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

52 Fillers, Diluents & Binders, 41 Coating Systems & Additives, 28 Parenteral, 28 Direct Compression, 27 Thickeners and Stabilizers, 25 Solubilizers, 21 Granulation, 18 Film Formers & Plasticizers, 18 Controlled & Modified Release, 17 Disintegrants & Superdisintegrants, 17 Taste Masking, 15 Topical, 12 Lubricants & Glidants, 12 Co-Processed Excipients, 9 Chewable & Orodispersible Aids, 9 Emulsifying Agents, 6 Surfactant & Foaming Agents, 5 Empty Capsules, 5 API Stability Enhancers, 5 Rheology Modifiers, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

4 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 284 News #PharmaBuzz

GLOBAL SALES INFORMATION

39 US Medicaid Prescriptions, 47 Regulatory FDF Prices, 7 Annual Reports

MARKET PLACE

70 APIs, 61 FDF Dossiers

PATENTS & EXCLUSIVITIES

17 US Patents, 2 US Exclusivities, 5 Health Canada Patents

REF. STANDARDS & IMPURITIES

8 EDQM, 6 USP, 2 JP, 16 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

ELIXIR;ORAL - 0.5MG/5ML

TABLET;ORAL - 4MG

OINTMENT;OPHTHALMIC - 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM

TABLET;ORAL - 2MG

TABLET;ORAL - 0.75MG

SUSPENSION/DROPS;OTIC - 0.3%;0.1%

SUSPENSION/DROPS;OPHTHALMIC - 0.1%;0.3%

OINTMENT;OPHTHALMIC - 0.1%;0.3%

SOLUTION;ORAL - 0.5MG/5ML

CONCENTRATE;ORAL - 1MG/ML

SUSPENSION/DROPS;OPHTHALMIC - 0.05%;0.3%

SUSPENSION/DROPS;OPHTHALMIC - 0.1%

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Dexamethasone

Dexamethasone

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

93 API Suppliers

27 USDMF

13 CEP/COS

6 JDMF

4 EU WC

7 KDMF

26 NDC API

1 VMF

51 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

411 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

526 FDF Dossiers

131 FDA Orange Book

271 Europe

26 Canada

10 Australia

18 South Africa

70 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OPHTHALMIC - 0.1%

SUSPENSION/DROPS;OTIC - 0.3%;0.1%

OINTMENT;OPHTHALMIC - 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM

SUSPENSION/DROPS;OPHTHALMIC - 0.1%;0.3%

OINTMENT;OPHTHALMIC - 0.1%;0.3%

SUSPENSION/DROPS;OPHTHALMIC - 0.05%;0.3%

TABLET;ORAL - 0.5MG

TABLET;ORAL - 0.75MG

TABLET;ORAL - 1.5MG

TABLET;ORAL - 1MG

TABLET;ORAL - 2MG

TABLET;ORAL - 4MG

TABLET;ORAL - 6MG

SOLUTION;ORAL - 0.5MG/5ML

CONCENTRATE;ORAL - 1MG/ML

ELIXIR;ORAL - 0.5MG/5ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI

3 Rochem International Inc

7 SPI Pharma

1 Pharm-RX Chemical

6 Gangwal Healthcare

6 Nanjing Well Pharmaceutical

1 Pfanstiehl

9 Kirsch Pharma

1 ACG Worldwide

15 Actylis

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

6 BASF

3 CD Formulation

10 Corel Pharma Chem

1 Curia

6 DFE Pharma

3 Finar

8 Gangwal Chemicals

2 Gloria Interchem

4 Ideal Cures

3 Ingredion Pharma Solutions

23 Kerry

2 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

13 Microlex e.U

1 Nanjing Bold Chemical

1 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

1 Novo Excipients

1 Pharmatrans-Sanaq

5 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd